Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
March 13, 2019 8:30 AM 3 min read

Stock Market Press Focuses on Pets and CBD With News of Metatron, Inc. Expanding Their Reach To Pet CBD; Other Companies Discussed Include Aurora Cannabis Inc. and Canopy Growth Corporation

by ACCESS Newswire
Follow

NEW YORK, NY / ACCESSWIRE / March 13, 2019 / Stock Market Press (SMP) focuses on the rapidly growing Pet CBD market. Companies covered in this spotlight include Aurora Cannabis Inc. (NYSE:ACB), Canopy Growth Corporation (TSX:WEED), (NYSE:CGC) and Metatron, Inc. (OTC:MRNJ).

With the recent passage and enactment of the 2018 Farm Bill, the USA federal regulations on Hemp have been lifted, opening up the doors to a hemp boom. Superior quality, along with increased production, are seeing prices drop and more companies expanding their CBD products to include the pet market. In the USA alone, the general pet market is expected to have topped $72B for 2018, an increase of almost 4% from 2017's $69.5B. With the advent of increased Pet CBD products, 2019 could see a much larger increase. Enter PetMojo and Metatron, Inc. (OTC:MRNJ).

Metatron, Inc. (OTC:MRNJ) just announced they have secured a deal with PetMojo, a company with over 20 years experience in eCommerce and 15 years experience running luxury pet services businesses. Through their combined talents, PetMojo and Metatron, Inc. (OTC:MRNJ) are going to develop and market a new Pet CBD product sales App for both iTunes and Google Play users.

''Pet-and-animal product CBD sales are estimated to reach $125 million by 2022, representing a 5-year CAGR of 57 percent, among the fastest-growing sectors in the CBD market.'' - Metatron, Inc. Press Release.

Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) has received approval to being researching the effectiveness of cannabidiol (''CBD'') to treat anxiety in certain animals. Marc Wayne, Managing Director, Canopy Health Innovations commented, ''The use of natural-occurring cannabinoids as a therapy for companion animals is a logical new forefront of medical discovery and the research we are working on at CAH is world leading. These trial approvals mark a significant milestone on the journey of making cannabis-based drugs accepted and recommended by veterinarians.''

Metatron, Inc. (OTC:MRNJ) is tapping into another huge market, increasing both their product exposure as well as revenues, since the majority of CBD pet products are sold online.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.

Contact:

Stock Market Press
110 Wall St.
New York, NY 10005
[email protected]
https://twitter.com/PressStock

Safe Harbor Statement:

See Stock Market Press disclaimer: http://stockmarketpress.com/disclaimer/

SOURCE: Stock Market Press

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsPress Releases
ACB Logo
ACBAurora Cannabis Inc
$3.800.26%
Overview
CGC Logo
CGCCanopy Growth Corp
$1.17-%
MRNJ Logo
MRNJMetatron Inc
$0.000001-%

The CBD market growth is worldwide, even a country like Germany is seeing its market opening up. Companies like Aurora Cannabis Inc. (NYSE:ACB) can now expand sales of cannabis oil to German pharmacies after receiving approval. They are making the difficult inroads that will allow companies like PetMojo and Metatron, Inc. (OTC:MRNJ) to bring their products to the German pet owning population, a group who cares for over 34M pets.

Statements in this news release may be ''forward-looking statements.'' Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

ACB Logo
ACBAurora Cannabis Inc
$3.800.26%
Overview
CGC Logo
CGCCanopy Growth Corp
$1.17-%
MRNJ Logo
MRNJMetatron Inc
$0.000001-%
Comments
Loading...